- Report
- April 2026
- 146 Pages
Global
From €2683EUR$2,999USD£2,299GBP
€3577EUR$3,999USD£3,065GBP
- Report
- April 2026
- 138 Pages
Global
From €2683EUR$2,999USD£2,299GBP
€3577EUR$3,999USD£3,065GBP
- Report
- April 2026
- 138 Pages
Global
From €2683EUR$2,999USD£2,299GBP
€3577EUR$3,999USD£3,065GBP
- Report
- January 2026
- 182 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- January 2026
- 292 Pages
Global
From €2236EUR$2,500USD£1,916GBP
- Report
- September 2026
- 179 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 189 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 471 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 197 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 177 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 368 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 486 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 279 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 288 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 375 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 476 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 464 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 280 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 368 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 451 Pages
Global
From €5233EUR$5,850USD£4,484GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more